ATE511829T1 - Fsh-glykosylierungsmutante - Google Patents
Fsh-glykosylierungsmutanteInfo
- Publication number
- ATE511829T1 ATE511829T1 AT04783331T AT04783331T ATE511829T1 AT E511829 T1 ATE511829 T1 AT E511829T1 AT 04783331 T AT04783331 T AT 04783331T AT 04783331 T AT04783331 T AT 04783331T AT E511829 T1 ATE511829 T1 AT E511829T1
- Authority
- AT
- Austria
- Prior art keywords
- fsh
- glycosylation mutant
- mutant
- fsh glycosylation
- lifes
- Prior art date
Links
- 230000013595 glycosylation Effects 0.000 title abstract 2
- 238000006206 glycosylation reaction Methods 0.000 title abstract 2
- 230000001186 cumulative effect Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49980203P | 2003-09-02 | 2003-09-02 | |
| PCT/US2004/029042 WO2005020934A2 (en) | 2003-09-02 | 2004-09-02 | Fsh glycosylation mutant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE511829T1 true ATE511829T1 (de) | 2011-06-15 |
Family
ID=34272871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04783331T ATE511829T1 (de) | 2003-09-02 | 2004-09-02 | Fsh-glykosylierungsmutante |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7700112B2 (de) |
| EP (1) | EP1694271B1 (de) |
| JP (1) | JP4653090B2 (de) |
| KR (1) | KR101099809B1 (de) |
| CN (1) | CN1984926B (de) |
| AT (1) | ATE511829T1 (de) |
| AU (1) | AU2004268683B2 (de) |
| BR (1) | BRPI0413206A (de) |
| CA (1) | CA2535522A1 (de) |
| CY (1) | CY1112439T1 (de) |
| DK (1) | DK1694271T3 (de) |
| EA (1) | EA012175B1 (de) |
| ES (1) | ES2367784T3 (de) |
| HK (1) | HK1101315A1 (de) |
| HR (1) | HRP20110430T1 (de) |
| IL (1) | IL174037A0 (de) |
| MX (1) | MXPA06002119A (de) |
| NO (1) | NO20061446L (de) |
| PL (1) | PL1694271T3 (de) |
| PT (1) | PT1694271E (de) |
| SI (1) | SI1694271T1 (de) |
| UA (1) | UA88879C2 (de) |
| WO (1) | WO2005020934A2 (de) |
| ZA (1) | ZA200601803B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2390263A1 (de) | 2005-08-26 | 2011-11-30 | Ares Trading S.A. | Verfahren zur Herstellung von glycosyliertem Interferon beta |
| JP5199112B2 (ja) * | 2005-12-09 | 2013-05-15 | アレス トレーディング ソシエテ アノニム | Ｆｓｈ又はｆｓｈ変異体を精製するための方法 |
| EP1976872B1 (de) * | 2005-12-22 | 2015-06-17 | Merck Serono SA | Fsh-mutanten |
| CA2633844A1 (en) * | 2006-01-17 | 2007-07-26 | Laboratoires Serono S.A. | Novel fsh glycosylation variant d3n |
| CN101679525B (zh) * | 2007-03-26 | 2013-06-19 | 诺瓦提斯公司 | 用于监测肾功能的预测性的肾安全性生物标志物和生物标志物标签 |
| AR081755A1 (es) | 2010-04-02 | 2012-10-17 | Hanmi Holdings Co Ltd | Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo |
| CN108676096B (zh) * | 2018-05-22 | 2022-03-29 | 北京伟杰信生物科技有限公司 | 重组猪fsh-ctp融合蛋白及其制备方法与应用 |
| WO2021092358A1 (en) * | 2019-11-06 | 2021-05-14 | The Regents Of The University Of Colorado, A Body Corporate | Modified follicle-stimulating hormone and methods of using the same |
| CN114213523A (zh) * | 2021-11-15 | 2022-03-22 | 广州源博医药科技有限公司 | 一种用于重组蛋白的高糖基化修饰序列及其重组猪促卵泡激素和应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5156957A (en) | 1983-11-02 | 1992-10-20 | Genzyme Corporation | Follicle stimulating hormone |
| US4840896A (en) | 1983-11-02 | 1989-06-20 | Integrated Genetics, Inc. | Heteropolymeric protein |
| US5639639A (en) | 1983-11-02 | 1997-06-17 | Genzyme Corporation | Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof |
| US4923805A (en) | 1983-11-02 | 1990-05-08 | Integrated Genetics, Inc. | Fsh |
| US4845077A (en) | 1984-04-03 | 1989-07-04 | Serono Laboratories, Inc. | Method of inducing ovulation |
| US4589402A (en) | 1984-07-26 | 1986-05-20 | Serono Laboratories, Inc. | Method of in vitro fertilization |
| US5338835A (en) | 1989-02-21 | 1994-08-16 | Washington University | CTP-extended form of FSH |
| DE69029799T2 (de) | 1989-02-21 | 1997-05-28 | Univ Washington | Modifizierte formen von fortpflanzungshormonen |
| US5508261A (en) | 1991-06-18 | 1996-04-16 | University Of Medicine & Dentistry Of New Jersey | Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same |
| US6407205B1 (en) | 1997-06-04 | 2002-06-18 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | FSH-releasing peptides |
| EP0994718B1 (de) * | 1997-06-20 | 2005-08-17 | Akzo Nobel N.V. | Gonadotropin releasing hormon antagonist |
| ATE329911T1 (de) * | 1998-08-07 | 2006-07-15 | Applied Research Systems | Fsh mimetika zur behandlung von infertilität |
| TR200401810T4 (tr) | 2000-01-27 | 2004-09-21 | Applied Research Systems Ars Holding N. V. | Kısırlık tedavisinde fsh'ın kullanılması |
| US20020127652A1 (en) * | 2000-02-11 | 2002-09-12 | Schambye Hans Thalsgard | Follicle stimulating hormones |
| AU2001231531A1 (en) * | 2000-02-11 | 2001-08-20 | Maxygen Aps | Follicle stimulating hormones |
| WO2004050679A2 (en) | 2001-10-22 | 2004-06-17 | Applied Research Systems Ars Holding N.V. | Mutant glycoproteins |
-
2004
- 2004-02-09 UA UAA200603350A patent/UA88879C2/ru unknown
- 2004-09-02 KR KR1020067004084A patent/KR101099809B1/ko not_active IP Right Cessation
- 2004-09-02 ES ES04783331T patent/ES2367784T3/es active Active
- 2004-09-02 MX MXPA06002119A patent/MXPA06002119A/es active IP Right Grant
- 2004-09-02 EP EP04783331A patent/EP1694271B1/de active Active
- 2004-09-02 AU AU2004268683A patent/AU2004268683B2/en not_active Ceased
- 2004-09-02 EA EA200600526A patent/EA012175B1/ru not_active IP Right Cessation
- 2004-09-02 SI SI200431701T patent/SI1694271T1/sl unknown
- 2004-09-02 CA CA002535522A patent/CA2535522A1/en not_active Abandoned
- 2004-09-02 WO PCT/US2004/029042 patent/WO2005020934A2/en active Application Filing
- 2004-09-02 US US10/934,707 patent/US7700112B2/en not_active Expired - Fee Related
- 2004-09-02 ZA ZA200601803A patent/ZA200601803B/en unknown
- 2004-09-02 BR BRPI0413206-8A patent/BRPI0413206A/pt not_active IP Right Cessation
- 2004-09-02 CN CN2004800326655A patent/CN1984926B/zh not_active Expired - Fee Related
- 2004-09-02 PL PL04783331T patent/PL1694271T3/pl unknown
- 2004-09-02 AT AT04783331T patent/ATE511829T1/de active
- 2004-09-02 PT PT04783331T patent/PT1694271E/pt unknown
- 2004-09-02 DK DK04783331.4T patent/DK1694271T3/da active
- 2004-09-02 JP JP2006525513A patent/JP4653090B2/ja not_active Expired - Fee Related
-
2006
- 2006-03-01 IL IL174037A patent/IL174037A0/en unknown
- 2006-03-30 NO NO20061446A patent/NO20061446L/no not_active Application Discontinuation
-
2007
- 2007-08-30 HK HK07109465.0A patent/HK1101315A1/xx not_active IP Right Cessation
-
2011
- 2011-06-08 HR HR20110430T patent/HRP20110430T1/hr unknown
- 2011-07-19 CY CY20111100704T patent/CY1112439T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR101099809B1 (ko) | 2011-12-27 |
| AU2004268683A2 (en) | 2005-03-10 |
| EP1694271A2 (de) | 2006-08-30 |
| HK1101315A1 (en) | 2007-10-12 |
| ZA200601803B (en) | 2007-05-30 |
| UA88879C2 (en) | 2009-12-10 |
| JP2007508245A (ja) | 2007-04-05 |
| PT1694271E (pt) | 2011-07-07 |
| CY1112439T1 (el) | 2015-12-09 |
| EA200600526A1 (ru) | 2007-04-27 |
| CN1984926A (zh) | 2007-06-20 |
| AU2004268683B2 (en) | 2010-06-24 |
| IL174037A0 (en) | 2006-08-01 |
| HRP20110430T1 (hr) | 2011-07-31 |
| JP4653090B2 (ja) | 2011-03-16 |
| EP1694271B1 (de) | 2011-06-08 |
| AU2004268683A1 (en) | 2005-03-10 |
| DK1694271T3 (da) | 2011-09-12 |
| CN1984926B (zh) | 2012-04-11 |
| BRPI0413206A (pt) | 2006-10-03 |
| WO2005020934A3 (en) | 2007-02-15 |
| PL1694271T3 (pl) | 2011-11-30 |
| EA012175B1 (ru) | 2009-08-28 |
| US20050100989A1 (en) | 2005-05-12 |
| US7700112B2 (en) | 2010-04-20 |
| NO20061446L (no) | 2006-03-30 |
| KR20070029620A (ko) | 2007-03-14 |
| MXPA06002119A (es) | 2006-05-31 |
| SI1694271T1 (sl) | 2011-08-31 |
| WO2005020934A2 (en) | 2005-03-10 |
| CA2535522A1 (en) | 2005-03-10 |
| ES2367784T3 (es) | 2011-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1112439T1 (el) | Μεταλλαγμα fsh-γλυκοζυλιωσης | |
| AU2003272536A8 (en) | Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin | |
| DE60115842D1 (de) | Ventilanordnung | |
| AU2003264282A1 (en) | Phenethanolamine derivatives and their use in the treatment of respiratory diseases | |
| HK1069316A1 (en) | Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases | |
| IL172396A0 (en) | Replikin peptides and uses thereof | |
| DE60205067D1 (de) | Einfach an jeden Zahnarztstuhl und/oder Operationstisch anpassbare Armstütze | |
| HUP9900681A2 (hu) | TH1/TH2-citokinexpresszió modulálása Ribavirinnel és Ribavirin-analógokkal, aktivált T-limfocitákban | |
| EP1536834A4 (de) | Entwurf von chemokin-analoga zur behandlung von erkrankungen des menschen | |
| DE60115432D1 (de) | Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen | |
| EA200870177A1 (ru) | Новый гликозилированный вариант fsh d3n | |
| WO2002076313A8 (fr) | Extenseur de l'os maxillaire | |
| MX2008008322A (es) | Mutantes de fsh. | |
| ITTO20020684A1 (it) | Nuovo uso dell'angelicina e di suoi analoghi strutturali. | |
| ES2094757T3 (es) | Un factor megacariocitopoyetico. | |
| AU2003281257A8 (en) | A novel use of rapamycin and structural analogues thereof | |
| WO2004050679A3 (en) | Mutant glycoproteins | |
| AU2002364889A8 (en) | Methods for diagnosis and treatment of diseases associated with altered expression of nrf2 | |
| CN2345194Y (zh) | 一种扣叩器 | |
| ATE95995T1 (de) | Ergonomisches kopfkissen, insbesondere zur verhuetung und/oder behandlung von nackenbeschwerden. | |
| BR8000814U (pt) | Instrumento de massagem à vácuo | |
| GR990100106A (el) | Οργανο παθητικης κινησιοθεραπειας σε ορθια θεση για ατομα με αναπηρια στα κατω ακρα | |
| SE9704451D0 (sv) | New method and compositions for the treatment of autoimmune diseases | |
| TW200509922A (en) | Methods of therapeutic treatment using amounts of retinoid components | |
| TW519919U (en) | Structure of health care chair capable of performing therapeutic ch'I-gong with biological spectrum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1694271 Country of ref document: EP |